Skip to main content
Premium Trial:

Request an Annual Quote

Lancet Endorses NAS Report on Open Access to Genomes

NEW YORK, Sept. 24 (GenomeWeb News) - An editorial in this week's Lancet supports the free and open access to genome databases, endorsing a report recently published by a panel organized by the US National Academies of Science.


The report, entitled "Seeking security: pathogens, open access, and genome databases," was released on Sept. 9. "The panel concluded, rightly, that current policies should remain unchanged," the Lancet editors write.


At the moment, researchers can freely access, over the Internet, gene sequences from more than 130,000 species, including the complete genome sequences of more than 1,000 viruses and bacteria as well as numerous plants, fungi, and animals.


The current open-access policies not only have practical advantages, the editors write. "They present the world with a model of international cooperation, trust, and altruism that offers a compelling alternative to the worldview of those who would use bioweapons to impose their political and ideological views."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.